Germany - medicaments

Description

Name: Non-ionic iodine-containing monomeric low osmolar water-soluble nephrotropic X-ray contrast mediumApplication: intraarterial and intravenous and intracavitary. Other possible fields of application:- urography,- computer tomography,- angiography,- digital subtraction angiography (DSA),- angiocardiography, coronary arteriography, interventional coronary arteriography,- fistulography, galactography.Dosage forms: all approved dosage forms of an active substance must be offeredConcentration: 400 mg/mlPackage size: all approved package sizes of an active substance must be offered Further information can be found in Annex 11 to the invitation to tender. Name: Non-ionic iodine-containing dimeric low osmolar water-soluble nephrotropic X-ray contrast mediumApplication: intraarterial and intravenous. Other possible areas of application:- Cerebral angiography, abdominal angiography, peripheral arteriography, venography,- urography,- contrast enhancement in computed tomography (CT).Concentrations: must be offered cumulatively:1 270 mg/ml2 320 mg/ml(all concentrations of an active substance must be offered, all areas of application must be covered at least together)Package size: all approved package sizes of an active substance must be offeredFurther information is given in Annex 11 to the invitation to tender. Name: Paramagnetic extracellular linear contrast agent for MRI application: Intra-articular useFields of application:- direct magnetic resonance arthrography.NSF Risk: high NSF Risk Class Pharmaceutical Form: all pharmaceutical forms of the active substance for this indicationConcentration: 0.002 mmol/mlPackage size: all package sizes of the active substance for this indicationFurther details are given in Annex 11 to the invitation to tender. Name: Paramagnetic extracellular macrocyclic contrast media for MRI application: intraarticular applicationApplications: direct magnetic resonance arthrographyNSF Risk: low NSF Risk Class Pharmaceutical Form: all pharmaceutical forms of the active substance for this indicationConcentration: 0.0025 mmol/mlPackage size: all package sizes of the active substance for this indicationFurther details are given in Annex 11 to the invitation to tender. Name: Paramagnetic extracellular linear contrast medium for MRI with renal excretion and partial biliary excretion Application: intravenous. NSF risk: average NSF risk Dosage form: all approved dosage forms of an active substance Concentration: all concentrations possiblePackage size: all approved package sizes of the active substance Further information can be found in Annex 11 to the invitation to tender. Name: Paramagnetic combines extracellular and hepatobiliary linear contrast media for MRI (excretion 50-50) application: Intravenous use. Further possibleApplication areas:- MRT of the liverNSF Risk: medium NSF Risk classDisposition form: all dosage forms of the active substanceConcentration: all concentrations possiblePackage size: all package sizes of the active substanceFurther information can be found in Annex 11 to the invitation to tender. Name: Ultrasonic contrast medium application: Intravenous applicationFields of application: Echocardiography, other possibleActive substances/combinations (ATC): Phospholipid microspheres containing perflutrene (V08DA04)Dosage form: all dosage formsConcentration: all concentrations possiblePackage size: all package sizesFurther information can be found in Annex 11 to the invitation to tender. Name: Ultrasonic contrast medium application: Intravenous applicationFields of application: Echocardiography, other possibleActive substances/combinations (ATC): Albumin microspheres, perfluorinated (V08DA01)Dosage form: All dosage formsConcentration: All concentrationsPackage size: All package sizesAdditional information is given in Appendix 11 to the invitation to tender. Name: Ultrasonic contrast medium application: Intravenous applicationFields of application: Echocardiography, Doppler sonography of the liver and breast, ultrasound of the urinary tractActive substances/combinations (ATC): Sulphur hexafluoride (V08DA05)Pharmaceutical Form: All Pharmaceutical FormsConcentration: All ConcentrationsPackage Size: All Package SizesAdditional information can be found in Appendix 11 to the Invitation to Tender.

Opportunity closing date

15 May 2021

Value of contract

to be confirmed